Related references
Note: Only part of the references are listed.Non-viral precision T cell receptor replacement for personalized cell therapy
Susan P. P. Foy et al.
NATURE REVIEWS DRUG DISCOVERY (2023)
Disruption of HIV-1 co-receptors CCR5 and CXCR4 in primary human T cells and hematopoietic stem and progenitor cells using base editing
Friederike Knipping et al.
MOLECULAR THERAPY (2022)
Prolonged viral suppression with anti-HIV-1 antibody therapy
Christian Gaebler et al.
NATURE (2022)
Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial
Jesper D. Gunst et al.
NATURE MEDICINE (2022)
Phase 1 clinical trial of CRISPR-engineered CAR19 universal T cells for treatment of children with refractory B cell leukemia
Giorgio Ottaviano et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
Genome editing of donor-derived T cells to generate allogeneic chimeric antigen receptor-modified T cells: optimizing αβ T-cell-depleted haploidentical hematopoietic stem cell transplantation
Volker Wiebking et al.
HAEMATOLOGICA (2021)
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
Nikhil C. Munshi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication
Pablo Tebas et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Broadly neutralizing antibody derived CAR T cells reduce viral reservoir in individuals infected with HIV-1
Bingfeng Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity
Julia Niessl et al.
NATURE MEDICINE (2020)
The Development of Next-generation PBMC Humanized Mice for Preclinical Investigation of Cancer Immunotherapeutic Agents
Y. Maurice Morillon et al.
ANTICANCER RESEARCH (2020)
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape
Mohamad Hamieh et al.
NATURE (2019)
Two-Dimensional Droplet Digital PCR as a Tool for Titration and Integrity Evaluation of Recombinant Adeno-Associated Viral Vectors
Birei Furuta-Hanawa et al.
HUMAN GENE THERAPY METHODS (2019)
CAR Talk: How Cancer-Specific CAR T Cells Can Instruct How to Build CAR T Cells to Cure HIV
Gloria B. Kim et al.
FRONTIERS IN IMMUNOLOGY (2019)
CRISPR-Cas: a tool for cancer research and therapeutics
Hao Yin et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
CRISPR/Cas9 genome editing in human hematopoietic stem cells
Rasmus O. Bak et al.
NATURE PROTOCOLS (2018)
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
Jae H. Park et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Glioblastoma-targeted CD4+ CAR T cells mediate superior antitumor activity
Dongrui Wang et al.
JCI INSIGHT (2018)
Engineering HIV-Resistant, Anti-HIV Chimeric Antigen Receptor T Cells
Malika Hale et al.
MOLECULAR THERAPY (2017)
Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
Justin Eyquem et al.
NATURE (2017)
Antibody 10-1074 suppresses viremia in HIV-1-infected individuals
Marina Caskey et al.
NATURE MEDICINE (2017)
Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
Stephen J. Schuster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Genome editing of the HIV co-receptors CCR5 and CXCR4 by CRISPR-Cas9 protects CD4+ T cells from HIV-1 infection
Zhepeng Liu et al.
CELL AND BIOSCIENCE (2017)
Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo
D. Sommermeyer et al.
LEUKEMIA (2016)
A Simple Mouse Model for the Study of Human Immunodeficiency Virus
Kang Chang Kim et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2016)
CD19 CAR-T cells of defined CD4+: CD8+ composition in adult B cell ALL patients
Cameron J. Turtle et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
HIV-1-Specific Chimeric Antigen Receptors Based on Broadly Neutralizing Antibodies
Ayub Ali et al.
JOURNAL OF VIROLOGY (2016)
Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy
Bingfeng Liu et al.
JOURNAL OF VIROLOGY (2016)
Novel CD4-Based Bispecific Chimeric Antigen Receptor Designed for Enhanced Anti-HIV Potency and Absence of HIV Entry Receptor Activity
Li Liu et al.
JOURNAL OF VIROLOGY (2015)
Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells
Ayal Hendel et al.
NATURE BIOTECHNOLOGY (2015)
Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
Pablo Tebas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
CD4+T-cell depletion in HIV infection: mechanisms of immunological failure
Afam A. Okoye et al.
IMMUNOLOGICAL REVIEWS (2013)
Antibodies in HIV-1 Vaccine Development and Therapy
Florian Klein et al.
SCIENCE (2013)
Engineering HIV-1-Resistant T-Cells from Short-Hairpin RNA-Expressing Hematopoietic Stem/Progenitor Cells in Humanized BLT Mice
Gene-Errol E. Ringpis et al.
PLOS ONE (2012)
Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells
John Scholler et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex
M. A. King et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Nef-mediated enhancement of virion infectivity and stimulation of viral replication are fundamental properties of primate lentiviruses
Jan Muench et al.
JOURNAL OF VIROLOGY (2007)
Towards a cellular definition of CD8+ T-cell memory:: the role of CD4+ T-cell help in CD8+ T-cell responses
B Rocha et al.
CURRENT OPINION IN IMMUNOLOGY (2004)
A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy
SG Deeks et al.
MOLECULAR THERAPY (2002)
Prolonged survival and tissue trafficking following adoptive transfer of CD4ζ gene-modified autologous CD4+ and CD8+ T cells in human immunodeficiency virus-infected subjects
RT Mitsuyasu et al.
BLOOD (2000)
Share Paper
